193 filings
ARS
2023 FY
COGT
Cogent Biosciences Inc
23 Apr 24
Annual report to shareholders
4:37pm
DEFA14A
COGT
Cogent Biosciences Inc
23 Apr 24
Additional proxy soliciting materials
4:34pm
DEF 14A
COGT
Cogent Biosciences Inc
Definitive proxy
23 Apr 24
4:32pm
PRE 14A
COGT
Cogent Biosciences Inc
Preliminary proxy
12 Apr 24
4:31pm
EFFECT
COGT
Cogent Biosciences Inc
11 Apr 24
Notice of effectiveness
12:15am
8-K
4rs7f
22 Mar 24
Unregistered Sales of Equity Securities
8:33am
S-8
6z7a91lp
26 Feb 24
Registration of securities for employees
4:34pm
8-K
sxbth
26 Feb 24
Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
8:30am
8-K
431q8xt
14 Feb 24
Cogent Biosciences Announces Oversubscribed $225 Million Private Placement
8:35am
8-K
kr2xwj2q8c6a2
11 Dec 23
Other Events
8:04am
8-K
4splhd3durzhz46u91eq
2 Nov 23
Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2023 Financial Results
9:18am
S-8
i4dvg02ux78bkii28rat
8 Aug 23
Registration of securities for employees
4:31pm
8-K
ai4dge0
8 Aug 23
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2023 Financial Results
8:14am
8-K
2k69odurwlgn23b27cp
8 Jun 23
Entry into a Material Definitive Agreement
4:31pm
424B5
mumimjbz
8 Jun 23
Prospectus supplement for primary offering
4:01pm
8-K
ol3xl7
7 Jun 23
Departure of Directors or Certain Officers
4:24pm